« back

MRC: Investigate SARS-CoV-2 vaccine responses and immune failure

  Tuesday, 08 Jun 2021 | Funding Deadline

Applications are invited for funding to investigate SARS-CoV-2 vaccine responses or immune failure. Your project must examine one or both of these:

• the nature and quality of SARS-CoV-2 vaccine responses
• the mechanisms of immune failure that lead to either SARS-CoV-2 re-infection or vaccine breakthrough.

This funding opportunity seeks to increase understanding of the immune response to SARS-CoV-2 vaccination in different demographic groups in order to support optimal implementation of vaccine delivery.

 

Deadline for proposals: 08 June 2021

Find out more here